Prostate Cancer Neurovascular Element Sparing with Stereotactic Ablative Radiation Therapy (SAbR): A Pilot Dosimetric Study for the POTEN-C Trial

Leiker A. J.; Rezaeian N. Hassan; Laine A. M.; Hannan R.; Folkert M. R.; Timmerman R. D.; Jia X.; Desai N. B.

首页> 外文期刊>International Journal of Radiation Oncology, Biology, Physics >Prostate Cancer Neurovascular Element Sparing with Stereotactic Ablative Radiation Therapy (SAbR): A Pilot Dosimetric Study for the POTEN-C Trial

【24h】

Prostate Cancer Neurovascular Element Sparing with Stereotactic Ablative Radiation Therapy (SAbR): A Pilot Dosimetric Study for the POTEN-C Trial

机译：前列腺癌神经血管元素与立体定向烧蚀疗法（SABR）：Poten-C试验的试验剂量测定研究

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《International Journal of Radiation Oncology, Biology, Physics 》 |2018年第3suppla期| 共1页
作者
Leiker A. J.; Rezaeian N. Hassan; Laine A. M.; Hannan R.; Folkert M. R.; Timmerman R. D.; Jia X.; Desai N. B.;
展开▼
作者单位

Univ Texas Southwestern Med Ctr Dallas Dept Radiat Oncol Dallas TX 75390 USA;

Univ Texas Southwestern Med Ctr Dallas Dept Radiat Oncol Dallas TX 75390 USA;

Univ Texas Southwestern Med Ctr Dallas Dept Radiat Oncol Dallas TX 75390 USA;

Univ Texas Southwestern Med Ctr Dallas Dept Radiat Oncol Dallas TX 75390 USA;

Univ Texas Southwestern Med Ctr Dallas Dept Radiat Oncol Dallas TX 75390 USA;

Univ Texas Southwestern Med Ctr Dallas Dept Radiat Oncol Dallas TX 75390 USA;

Univ Texas Southwestern Med Ctr Dallas Dept Radiat Oncol Dallas TX 75390 USA;

Univ Texas Southwestern Med Ctr Dallas Dept Radiat Oncol Dallas TX 75390 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类放射医学 ;
关键词

相似文献

外文文献
中文文献
专利

1. Prostate Cancer Neurovascular Element Sparing with Stereotactic Ablative Radiation Therapy (SAbR): A Pilot Dosimetric Study for the POTEN-C Trial [J] . Leiker A. J., Rezaeian N. Hassan, Laine A. M., International Journal of Radiation Oncology, Biology, Physics . 2018 ,第3Suppla期

机译：前列腺癌神经血管元素与立体定向烧蚀疗法（SABR）：Poten-C试验的试验剂量测定研究
2. Feasibility Study of Focal Salvage High Dose Rate (HDR) Brachytherapy After Neurovascular-Sparing Prostate Stereotactic Ablative Radiation Therapy (SAbR) [J] . Rezaeian N. Hassan, Gannavarapu B., Hannan R., Medical Physics . 2019 ,第6期

机译：神经血管滥本前列腺术型射击疗法（SABR）后局灶性救生高剂量率（HDR）近距离放射治疗的可行性研究（SABR）
3. Predicting Neurovascular Sparing in Function-Preserving Stereotactic Ablative Radiotherapy (SAbR) of Prostate Cancer: An Innovative Implementation of Deep Learning Technique [J] . Rezaeian N. Hassan, Gonzalez Y., Leiker A., Medical Physics . 2018 ,第6期

机译：预测前列腺癌功能保存型立体定向烧蚀放射治疗（SABR）的神经血管备受：深度学习技术的创新实施
4. CT image feature analysis in distinguishing radiation fibrosis from tumour recurrence after stereotactic ablative radiotherapy(SABR)for lung cancer: a preliminary study [C] . Sarah A. Mattonen, David A. Palma, Cornells J. A. Haasbeek, Conference on biomedical applications in molecular, structural, and functional imaging . 2013

机译：立体定向消融放疗（SABR）后肺癌的CT图像特征分析与放射复发的区别：初步研究
5. A comparative study of quality of life in patients with low-and intermediate-risk prostate cancer treated at a single institution: Stereotactic radiotherapy vs. high dose-rate brachytherapy monotherapy vs. high dose-rate brachytherapy boost [D] . Helou, Joelle. 2017

机译：单一机构治疗的中低危前列腺癌患者生活质量的比较研究：立体定向放疗与高剂量率近距离放射疗法单药疗法与高剂量率近距离放射疗法增强
6. The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I non-small cell lung cancer (NSCLC) considered to be at higher risk of complications from surgical resection [O] . M. P. Snee, L. McParland, F. Collinson, 2016

机译：SABRTooth可行性试验方案：一项研究用于确定在III期非小细胞肺癌（NSCLC）患者中进行立体定向消融放疗（SABR）与手术比较的III期随机对照试验的可行性和可接受性手术切除并发症的风险更高
7. Prostate Cancer Neurovascular Element Sparing with Stereotactic Ablative Radiation Therapy (SAbR): A Pilot Dosimetric Study for the POTEN-C Trial [O] . A.J. Leiker, N. Hassan Rezaeian, A.M. Laine, 2018

机译：前列腺癌神经血管元素与立体定向烧蚀疗法（SABR）：Poten-C试验的试验剂量测定研究
8. EF5 PET of Tumor Hypoxia: A Predictive Imaging Biomarker of Response to Stereotactic Ablative Radiotherapy (SABR) for Early Lung Cancer. [R] . Loo, B. J. W. 2017

机译：肿瘤缺氧的EF5 pET：早期肺癌立体定向烧蚀放疗（saBR）反应的预测成像生物标志物。

Prostate Cancer Neurovascular Element Sparing with Stereotactic Ablative Radiation Therapy (SAbR): A Pilot Dosimetric Study for the POTEN-C Trial

著录项

相似文献

相关主题

期刊订阅